1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    






















































































































    Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticlePEDIATRICS

  
      

  
      
Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients
  
    	
W.P. Miller, L.F. Mantovani, J. Muzic, J.B. Rykken, R.S. Gawande, T.C. Lund, R.M. Shanley, G.V. Raymond, P.J. Orchard and D.R. Nascene

  
    	
American Journal of Neuroradiology February 2016,  37 (2) 367-372; DOI: https://doi.org/10.3174/ajnr.A4500 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵
    1. 

    2. Engelen  M, 
    3. Kemp  S, 
    4. de Visser  M, et al
    . X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 2012;7:51 doi:10.1186/1750-1172-7-51 pmid:22889154
    CrossRefPubMed
  2. 2.↵
    1. 

    2. Moser  H, 
    3. Raymond  G, 
    4. Dubey  P
    . Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA 2005;294:3131–34 doi:10.1001/jama.294.24.3131 pmid:16380594
    CrossRefPubMed
  3. 3.↵
    1. 

    2. Mahmood  A, 
    3. Raymond  G, 
    4. Dubey  P, et al
    . Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study. Lancet Neurol 2007;6:687–92 doi:10.1016/S1474-4422(07)70177-1 pmid:17618834
    CrossRefPubMedWeb of Science
  4. 4.↵
    1. 

    2. Powers  JM, 
    3. Pei  Z, 
    4. Heinzer  AK, et al
    . Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol 2005;64:1067–79 doi:10.1097/01.jnen.0000190064.28559.a4 pmid:16319717
    CrossRefPubMed
  5. 5.↵
    1. 

    2. Powers  JM, 
    3. Liu  Y, 
    4. Moser  AB, et al
    . The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 1992;51:630–43 doi:10.1097/00005072-199211000-00007 pmid:1362438
    CrossRefPubMed
  6. 6.↵
    1. 

    2. Berger  J, 
    3. Forss-Petter  S, 
    4. Eichler  FS
    . Pathophysiology of X-linked adrenoleukodystrophy. Biochimie 2014;98:135–42 doi:10.1016/j.biochi.2013.11.023 pmid:24316281
    CrossRefPubMed
  7. 7.↵
    1. 

    2. Moser  HW, 
    3. Raymond  GV, 
    4. Lu  SE, et al
    . Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil. Arch Neurol 2005;62:1073–80 doi:10.1001/archneur.62.7.1073 pmid:16009761
    CrossRefPubMedWeb of Science
  8. 8.↵
    1. 

    2. Melhem  ER, 
    3. Loes  DJ, 
    4. Georgiades  CS, et al
    . X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression. AJNR Am J Neuroradiol 2000;21:839–44 pmid:10815658
    Abstract/FREE Full Text
  9. 9.↵
    1. 

    2. Loes  DJ, 
    3. Fatemi  A, 
    4. Melhem  ER, et al
    . Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003;61:369–74 doi:10.1212/01.WNL.0000079050.91337.83 pmid:12913200
    Abstract/FREE Full Text
  10. 10.↵
    1. 

    2. Loes  DJ, 
    3. Hite  S, 
    4. Moser  H, et al
    . Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994;15:1761–66 pmid:7847225
    Abstract/FREE Full Text
  11. 11.↵
    1. 

    2. Peters  C, 
    3. Charnas  LR, 
    4. Tan  Y, et al
    . Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004;104:881–88 doi:10.1182/blood-2003-10-3402 pmid:15073029
    Abstract/FREE Full Text
  12. 12.↵
    1. 

    2. Moser  HW, 
    3. Raymond  GV, 
    4. Koehler  W, et al
    . Evaluation of the preventive effect of glyceryl trioleate-trierucate (“Lorenzo's oil”) therapy in X-linked adrenoleukodystrophy: results of two concurrent trials. Adv Exp Med Biol 2003;544:369–87 doi:10.1007/978-1-4419-9072-3-47 pmid:14713253
    CrossRefPubMedWeb of Science
  13. 13.↵
    1. 

    2. Miller  WP, 
    3. Rothman  SM, 
    4. Nascene  D, et al
    . Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood 2011;118:1971–78 doi:10.1182/blood-2011-01-329235 pmid:21586746
    Abstract/FREE Full Text
  14. 14.↵
    1. 

    2. Appelbaum  FR, 
    3. Thomas  E
    . Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation. Oxford: Wiley-Blackwell; 2009
  15. 15.↵
    1. 

    2. Orchard  PJ, 
    3. Lund  T, 
    4. Miller  W, et al
    . Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy. J Neuroinflammation 2011;8:144 doi:10.1186/1742-2094-8-144 pmid:22014002
    CrossRefPubMed
  16. 16.↵
    1. 

    2. Fleiss  JL, 
    3. Levin  B, 
    4. Paik  MC
    . Statistical Methods for Rates and Proportions. New York: John Wiley & Sons; 2003
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients
  
    	
W.P. Miller, L.F. Mantovani, J. Muzic, J.B. Rykken, R.S. Gawande, T.C. Lund, R.M. Shanley, G.V. Raymond, P.J. Orchard, D.R. Nascene

  
    	
American Journal of Neuroradiology Feb 2016, 37 (2) 367-372; DOI: 10.3174/ajnr.A4500 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement